Today's guests are Melissa Easy, Vice President and General Manager of Clinical Technologies at IQVIA, and Tim Riely, Vice President of Clinical Data Analytics at IQVIA. They return to the program to talk with Emerj Senior Editor Matthew DeMello about the current state of AI in life sciences and clinical trials. Throughout the episode, Melissa and Tim underscore both the ongoing and impending impact of large language models on report writing and other clinical trials-oriented use cases.